Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Debes, Jose Daniel	University Of Minnesota United States	Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics	1R37CA297814-01	Sidney Fu, M.D.
Delaney, Joe R	Medical University Of South Carolina United States	Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma	1R21CA292343-01A1	Goli Samimi, Ph.D., M.P.H.
Demb, Joshua Brian	University Of California, San Diego United States	Optimal early colorectal cancer screening initiation	4R00CA267181-03	Claire Zhu, Ph.D.
Demehri, Shadmehr	Massachusetts General Hospital United States	Immunosurveillance of breast glands with oncogenic germline mutations	5UG3CA290300-02	Altaf Mohammed, Ph.D.
Deng, Gary E	University Of California-Irvine United States	Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial	7R21CA286330-03	Goli Samimi, Ph.D., M.P.H.
Deng, Jie	University Of Pennsylvania United States	Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema	1R01CA289307-01A1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Deng, Youping	University Of Hawaii At Manoa United States	Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms	5R01CA230514-05	Christos Patriotis, Ph.D., M.Sc.
Dhakal, Soma	Virginia Commonwealth University United States	Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers	5R61CA278445-03	Christos Patriotis, Ph.D., M.Sc.
Diaz, Juan Sebastian Gomez	University Of California At Davis United States	A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids	3R01CA273253-03S1	Nicholas Hodges, Ph.D.
Dickinson, Sally E	University Of Arizona United States	Investigating novel targets for topical immunoprevention of keratinocytic skin cancer	1UG3CA290443-01A1	Altaf Mohammed, Ph.D.
Digirolamo, Gregory James	Univ Of Massachusetts Med Sch Worcester United States	Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning	5R01CA269903-04
Doescher, Mark P	University Of Oklahoma Hlth Sciences Ctr United States	Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub	3UG1CA287044-02S1	Elyse LeeVan, M.D., M.P.H.
Doolittle, Gary C.	University Of Kansas Medical Center United States	The University of Kansas Cancer Center's- MCA Rural NCORP- extension	3UG1CA239767-06S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Drake, Richard R.	Medical University Of South Carolina United States	Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids	5R33CA267226-03
Drescher, Charles	Swedish Medical Center, First Hill United States	The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site	3UG1CA189953-11S1	Vanessa A. White, M.P.H.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants